[Molecular and epidemiologic aspects of the resistance to antibiotics: example of glycopeptides on enterococci]
Related Experiment Videos
1Centre National de la Résistance aux Antibiotiques, Institut Pasteur, Paris, France.
Comptes Rendus Des Seances De La Societe De Biologie Et De Ses Filiales
|January 1, 1996
Abstract:
The emergence of glycopeptide resistance in enterococci results in a severe clinical problem. Efforts to limit the spread of glycopeptide-resistant enterococci are now considered essential. The many ways in which the resistant strains can disseminate, both in the community and in hospitals, are a source of difficulty in reaching that goal.